Expanding the p53 regulatory network: LncRNAs take up the challenge.
暂无分享,去创建一个
[1] E. Appella,et al. Post-translational modifications and activation of p53 by genotoxic stresses. , 2001, European journal of biochemistry.
[2] Cole Trapnell,et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. , 2011, Genes & development.
[3] S. Dhanasekaran,et al. The landscape of long noncoding RNAs in the human transcriptome , 2015, Nature Genetics.
[4] Yu Fan,et al. TGF-β–Induced Upregulation of malat1 Promotes Bladder Cancer Metastasis by Associating with suz12 , 2014, Clinical Cancer Research.
[5] D. Largaespada,et al. PVT1 dependence in cancer with MYC copy-number increase , 2014, Nature.
[6] J. Rinn,et al. Integrative genomic analysis reveals widespread enhancer regulation by p53 in response to DNA damage , 2015, Nucleic acids research.
[7] N. Caplen,et al. p53-dependent Induction of PVT1 and miR-1204* , 2011, The Journal of Biological Chemistry.
[8] Michael Q. Zhang,et al. A long nuclear‐retained non‐coding RNA regulates synaptogenesis by modulating gene expression , 2010, EMBO Journal.
[9] C. Prives,et al. Transcriptional regulation by p53. , 2010, Cold Spring Harbor perspectives in biology.
[10] Zhaohui Feng,et al. The Regulation of Aging and Longevity: A New and Complex Role of p53. , 2011, Genes & cancer.
[11] M. Mhlanga,et al. lncRNA and gene looping , 2014, Transcription.
[12] K. Meletis,et al. p53 suppresses the self-renewal of adult neural stem cells , 2005, Development.
[13] J. Rinn,et al. lincRNAs act in the circuitry controlling pluripotency and differentiation , 2011, Nature.
[14] D. Bartel,et al. lincRNAs: Genomics, Evolution, and Mechanisms , 2013, Cell.
[15] Howard Y. Chang,et al. Extensive and coordinated transcription of noncoding RNAs within cell cycle promoters , 2011, Nature Genetics.
[16] M. Groudine,et al. Functional and Mechanistic Diversity of Distal Transcription Enhancers , 2011, Cell.
[17] C. Ponting,et al. Intergenic lncRNAs and the evolution of gene expression. , 2014, Current opinion in genetics & development.
[18] R. Kong,et al. Low expression of long noncoding RNA PANDAR predicts a poor prognosis of non-small cell lung cancer and affects cell apoptosis by regulating Bcl-2 , 2015, Cell Death and Disease.
[19] T. Ichisaka,et al. Suppression of induced pluripotent stem cell generation by the p53–p21 pathway , 2009, Nature.
[20] Runsheng Chen,et al. Functional Characterization of Long Noncoding RNA Lnc_bc060912 in Human Lung Carcinoma Cells. , 2015, Biochemistry.
[21] Fangting Wu,et al. LncRNA loc285194 is a p53-regulated tumor suppressor , 2013, Nucleic acids research.
[22] A. Hochberg,et al. H19 expression in hepatic metastases from a range of human carcinomas , 2005, Journal of Clinical Pathology.
[23] A. Hochberg,et al. The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma , 2000, Molecular pathology : MP.
[24] S. Nimer,et al. The p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior , 2009, Cell cycle.
[25] R. Tjian,et al. p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. , 1995, Science.
[26] Alberto Inga,et al. The expanding universe of p53 targets , 2009, Nature Reviews Cancer.
[27] R. Elkon,et al. eRNAs are required for p53-dependent enhancer activity and gene transcription. , 2013, Molecular cell.
[28] Maite Huarte,et al. Long non-coding RNAs and chromatin modifiers , 2014, Epigenetics.
[29] K. Sakaguchi,et al. Phosphorylation of human p53 by p38 kinase coordinates N‐terminal phosphorylation and apoptosis in response to UV radiation , 1999, The EMBO journal.
[30] Paulo P. Amaral,et al. Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. , 2008, Genome research.
[31] C. Méndez-Vidal,et al. Wrap53, a Natural p53 Antisense Transcript Required for p53 Induction upon DNA Damage. , 2016, Molecular cell.
[32] S. Lottin,et al. H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression. , 1998, The American journal of pathology.
[33] Lin Xu,et al. Upregulation of the long noncoding RNA TUG1 promotes proliferation and migration of esophageal squamous cell carcinoma , 2015, Tumor Biology.
[34] Feng Yang,et al. Up‐regulated long non‐coding RNA H19 contributes to proliferation of gastric cancer cells , 2012, The FEBS journal.
[35] Kotb Abdelmohsen,et al. LincRNA-p21 suppresses target mRNA translation. , 2012, Molecular cell.
[36] S. Lottin,et al. The human H19 gene is frequently overexpressed in myometrium and stroma during pathological endometrial proliferative events. , 2005, European journal of cancer.
[37] D. Reinberg,et al. CTCF regulates the human p53 gene through direct interaction with its natural antisense transcript, Wrap53 , 2014, Genes & development.
[38] Karen H. Vousden,et al. The ins and outs of p53 , 2000, Nature Cell Biology.
[39] Jinsong Yang,et al. Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma , 2014, Journal of Translational Medicine.
[40] J. Zhao,et al. Expression and Functional Role of Reprogramming-Related Long Noncoding RNA (lincRNA-ROR) in Glioma , 2015, Journal of Molecular Neuroscience.
[41] H. Hermeking,et al. MicroRNAs in the p53 network: micromanagement of tumour suppression , 2012, Nature Reviews Cancer.
[42] Yiran Huang,et al. Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. , 2013, Molecular bioSystems.
[43] G. Tseng,et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas , 2006, Hepatology.
[44] U. Gezer,et al. Investigation of circulating lncRNAs in B-cell neoplasms. , 2014, Clinica chimica acta; international journal of clinical chemistry.
[45] Jonathan R. Hall,et al. Long noncoding RNA lincRNA-p21 is the major mediator of UVB-induced and p53-dependent apoptosis in keratinocytes , 2015, Cell Death and Disease.
[46] Nadav S. Bar,et al. Landscape of transcription in human cells , 2012, Nature.
[47] Qiang Zhang,et al. Down-regulation of long non-coding RNA TUG1 inhibits osteosarcoma cell proliferation and promotes apoptosis. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[48] V. Villegas,et al. Neighboring Gene Regulation by Antisense Long Non-Coding RNAs , 2015, International journal of molecular sciences.
[49] Wilfried Haerty,et al. Considerations when investigating lncRNA function in vivo , 2014, eLife.
[50] Tae-Kyung Kim,et al. Emerging epigenetic mechanisms of long non-coding RNAs , 2014, Neuroscience.
[51] Yusuke Nakamura,et al. p53AIP1, a Potential Mediator of p53-Dependent Apoptosis, and Its Regulation by Ser-46-Phosphorylated p53 , 2000, Cell.
[52] G. Pavesi,et al. A perspective of promoter architecture from the CCAAT box , 2009, Cell cycle.
[53] C. Kay,et al. p53 tumour suppressor gene polymorphism is associated with recurrent implantation failure. , 2006, Reproductive biomedicine online.
[54] A. Levine,et al. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.
[55] J. Rinn,et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression , 2009, Proceedings of the National Academy of Sciences.
[56] D. Danila,et al. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. , 2003, The Journal of clinical endocrinology and metabolism.
[57] J. Hou,et al. Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer , 2014, Oncotarget.
[58] L. Bernd,et al. Prognostic significance of drug-regulated genes in high-grade osteosarcoma , 2007, Modern Pathology.
[59] Lin Zhao,et al. LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis , 2014, Cell Death and Disease.
[60] R. Grover,et al. Polypyrimidine tract binding protein regulates IRES-mediated translation of p53 isoforms , 2008, Cell cycle.
[61] Y. Mo,et al. The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage , 2012, Cell Research.
[62] Reuven Agami,et al. Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA , 2015, Nature Communications.
[63] J. Rinn,et al. A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response , 2010, Cell.
[64] H. Tse,et al. The p53-induced lincRNA-p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters , 2014, Cell Research.
[65] J. Rinn,et al. Pint lincRNA connects the p53 pathway with epigenetic silencing by the Polycomb repressive complex 2 , 2013, Genome Biology.
[66] Michael Thomas,et al. MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer , 2003, Oncogene.
[67] Leighton J. Core,et al. Nascent RNA Sequencing Reveals Widespread Pausing and Divergent Initiation at Human Promoters , 2008, Science.
[68] C. Sensen,et al. LincRNA-p21 acts as a mediator of ING1b-induced apoptosis , 2015, Cell Death and Disease.
[69] H. Hermeking,et al. Mediation of c-Myc-induced apoptosis by p53. , 1994, Science.
[70] Howard Y. Chang,et al. Genome regulation by long noncoding RNAs. , 2012, Annual review of biochemistry.
[71] E. White,et al. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. , 1993, Genes & development.
[72] Xiaoping Zhou,et al. Linc-RNA-RoR acts as a "sponge" against mediation of the differentiation of endometrial cancer stem cells by microRNA-145. , 2014, Gynecologic oncology.
[73] M. Noguchi,et al. Phenotypic characterization of endometrial stromal sarcoma of the uterus , 2006, Cancer science.
[74] G. Natoli,et al. Noncoding transcription at enhancers: general principles and functional models. , 2012, Annual review of genetics.
[75] O. Fodstad,et al. Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer. , 2013, Clinical colorectal cancer.
[76] P. Pineau,et al. Long noncoding RNA PANDA and scaffold-attachment-factor SAFA control senescence entry and exit , 2014, Nature Communications.
[77] Katsuki Ito,et al. Loss of H19 imprinting in esophageal cancer. , 1996, Cancer research.
[78] ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. , 2011, Cell.
[79] Yuechao Ding,et al. Expression of long non-coding RNA LOC285194 and its prognostic significance in human pancreatic ductal adenocarcinoma. , 2014, International journal of clinical and experimental pathology.
[80] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.
[81] Elke Hacker,et al. Melanoma cell invasiveness is regulated by miR‐211 suppression of the BRN2 transcription factor , 2011, Pigment cell & melanoma research.
[82] C. Prives,et al. Blinded by the Light: The Growing Complexity of p53 , 2009, Cell.
[83] Hiromu Suzuki,et al. Identification and analysis of large intergenic non-coding RNAs regulated by p53 family members through a genome-wide analysis of p53-binding sites. , 2014, Human molecular genetics.
[84] L. Marchionni,et al. hGTSE-1 Expression Stimulates Cytoplasmic Localization of p53* , 2004, Journal of Biological Chemistry.
[85] Benjamin G. Bitler,et al. NF-YA Underlies EZH2 Upregulation and Is Essential for Proliferation of Human Epithelial Ovarian Cancer Cells , 2013, Molecular Cancer Research.
[86] Yangchao Chen,et al. Targeting long non-coding RNAs in cancers: progress and prospects. , 2013, The international journal of biochemistry & cell biology.
[87] L. Diatchenko,et al. Correlation of transcription of MALAT-1, a novel noncoding RNA, with deregulated expression of tumor suppressor p53 in small DNA tumor virus models. , 2013, Journal of cancer therapy.
[88] T. Johnson,et al. Reduced expression of the Caenorhabditis elegans p53 ortholog cep-1 results in increased longevity. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.
[89] Min-hui Yang,et al. MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis. , 2011, International journal of oncology.
[90] Emily A. Vucic,et al. Human Cancer Long Non-Coding RNA Transcriptomes , 2011, PloS one.
[91] Y. Jiao,et al. Long intergenic non-coding RNA induced by X-ray irradiation regulates DNA damage response signaling in the human bronchial epithelial BEAS-2B cell line , 2014, Oncology letters.
[92] Christopher J. Lee,et al. A transcriptional sketch of a primary human breast cancer by 454 deep sequencing , 2009, BMC Genomics.
[93] P. Sharp,et al. LincRNA-p21 activates p21 in cis to promote Polycomb target gene expression and to enforce the G1/S checkpoint. , 2014, Molecular cell.
[94] R. Kong,et al. P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression , 2014, Cell Death and Disease.
[95] Maite Huarte,et al. Genome-wide analysis of the human p53 transcriptional network unveils a lncRNA tumour suppressor signature , 2014, Nature Communications.
[96] Yunli Zhou,et al. MEG3 noncoding RNA: a tumor suppressor. , 2012, Journal of molecular endocrinology.
[97] Zhiming Cai,et al. Long intergenic non‐coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder , 2013, Journal of surgical oncology.
[98] C. Prives,et al. Why Is p53 Acetylated? , 2001, Cell.
[99] C. Cepko,et al. The Noncoding RNA Taurine Upregulated Gene 1 Is Required for Differentiation of the Murine Retina , 2005, Current Biology.
[100] Jing Zhao,et al. Activation of p53 by MEG3 Non-coding RNA* , 2007, Journal of Biological Chemistry.
[101] Maite Huarte,et al. Long non-coding RNAs: challenges for diagnosis and therapies. , 2013, Nucleic acid therapeutics.
[102] C. Prives,et al. Getting p53 Out of the Nucleus , 2001, Science.
[103] F. Recillas-Targa,et al. Epigenetic regulation of the human p53 gene promoter by the CTCF transcription factor in transformed cell lines , 2010, Oncogene.
[104] H. Ashktorab,et al. MicroRNA-211 Expression Promotes Colorectal Cancer Cell Growth In Vitro and In Vivo by Targeting Tumor Suppressor CHD5 , 2012, PloS one.
[105] P. Wei,et al. Low expression of LOC285194 is associated with poor prognosis in colorectal cancer , 2013, Journal of Translational Medicine.
[106] G. Macino,et al. PVT1: A Rising Star among Oncogenic Long Noncoding RNAs , 2015, BioMed research international.
[107] M. Gorospe,et al. Long Noncoding RNA MALAT1 Controls Cell Cycle Progression by Regulating the Expression of Oncogenic Transcription Factor B-MYB , 2013, PLoS genetics.
[108] G. Dranitsaris,et al. CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes. , 2010, Leukemia research.
[109] Z. Zeng,et al. LOC401317, a p53-Regulated Long Non-Coding RNA, Inhibits Cell Proliferation and Induces Apoptosis in the Nasopharyngeal Carcinoma Cell Line HNE2 , 2014, PloS one.
[110] Wei Gu,et al. SnapShot: p53 Posttranslational Modifications , 2008, Cell.
[111] M. Mhlanga,et al. lncRNA and gene looping: what's the connection? , 2014, Transcription.
[112] Eduardo Sontag,et al. Transcriptional control of human p53-regulated genes , 2008, Nature Reviews Molecular Cell Biology.
[113] Ci Zhao,et al. LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the Wnt/β-catenin signaling pathway. , 2014, Oncology reports.
[114] M. Halaby,et al. The identification of an internal ribosomal entry site in the 5′-untranslated region of p53 mRNA provides a novel mechanism for the regulation of its translation following DNA damage , 2006, Oncogene.
[115] A. Hochberg,et al. Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma. , 1998, Molecular pathology : MP.
[116] D. Levens,et al. Isolation and Characterization of a Novel H1.2 Complex That Acts as a Repressor of p53-mediated Transcription* , 2008, Journal of Biological Chemistry.
[117] J. Rinn,et al. Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells , 2010, Nature Genetics.
[118] Rui Xia,et al. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16 , 2015, Molecular Cancer.
[119] Wen-Lin Kuo,et al. Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer , 2007, Clinical Cancer Research.
[120] Michael F. Lin,et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals , 2009, Nature.
[121] S. Batalov,et al. Antisense Transcription in the Mammalian Transcriptome , 2005, Science.
[122] A. Levine,et al. p53 regulates maternal reproduction through LIF , 2007, Nature.
[123] Junhua Zheng,et al. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma , 2015, Tumor Biology.
[124] David Malkin,et al. Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma. , 2010, Cancer research.
[125] Kotb Abdelmohsen,et al. Posttranscriptional gene regulation by long noncoding RNA. , 2013, Journal of molecular biology.
[126] A. Fatica,et al. Long non-coding RNAs: new players in cell differentiation and development , 2013, Nature Reviews Genetics.
[127] Zigang Dong,et al. Post-translational modification of p53 in tumorigenesis , 2004, Nature Reviews Cancer.